|
Watson Pharmaceuticals, Inc. - Comparative Business Analysis Snapshot
Business Description
Watson Pharmaceuticals, Inc.. The Group's principal activities are to develop, manufacture and market generic and brand pharmaceutical products. The Group operates through three segments: Branded, Generic and Distribution. The Branded segment serves the specialty markets in urology and nephrology. The Generic pharmaceutical products segment includes off-patent pharmaceutical products that are therapeutically equivalent to proprietary products. Distribution Segment consists of Anda, Anda Pharmaceuticals and Valmed. The Group markets their products to pharmaceutical wholesalers, drug distributors and chain drug stores.
Competitor Analysis
This analysis compares Watson Pharmaceuticals, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
